1. Home
  2. PWP vs TVTX Comparison

PWP vs TVTX Comparison

Compare PWP & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWP
  • TVTX
  • Stock Information
  • Founded
  • PWP 2006
  • TVTX 2008
  • Country
  • PWP United States
  • TVTX United States
  • Employees
  • PWP N/A
  • TVTX N/A
  • Industry
  • PWP Finance: Consumer Services
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PWP Finance
  • TVTX Health Care
  • Exchange
  • PWP Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • PWP 1.4B
  • TVTX 1.3B
  • IPO Year
  • PWP N/A
  • TVTX N/A
  • Fundamental
  • Price
  • PWP $16.83
  • TVTX $17.63
  • Analyst Decision
  • PWP Hold
  • TVTX Strong Buy
  • Analyst Count
  • PWP 3
  • TVTX 13
  • Target Price
  • PWP $25.33
  • TVTX $33.75
  • AVG Volume (30 Days)
  • PWP 929.8K
  • TVTX 1.8M
  • Earning Date
  • PWP 05-02-2025
  • TVTX 05-05-2025
  • Dividend Yield
  • PWP 1.63%
  • TVTX N/A
  • EPS Growth
  • PWP N/A
  • TVTX N/A
  • EPS
  • PWP N/A
  • TVTX N/A
  • Revenue
  • PWP $878,039,000.00
  • TVTX $233,175,000.00
  • Revenue This Year
  • PWP $14.00
  • TVTX $68.31
  • Revenue Next Year
  • PWP $14.49
  • TVTX $55.65
  • P/E Ratio
  • PWP N/A
  • TVTX N/A
  • Revenue Growth
  • PWP 35.36
  • TVTX 60.55
  • 52 Week Low
  • PWP $11.68
  • TVTX $5.12
  • 52 Week High
  • PWP $27.03
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • PWP 45.66
  • TVTX 54.86
  • Support Level
  • PWP $14.98
  • TVTX $14.13
  • Resistance Level
  • PWP $17.32
  • TVTX $15.23
  • Average True Range (ATR)
  • PWP 1.28
  • TVTX 1.21
  • MACD
  • PWP 0.21
  • TVTX 0.38
  • Stochastic Oscillator
  • PWP 78.32
  • TVTX 98.85

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: